GCG and type 2 diabetes mellitus: Incretin (DPP-4i and GLP-1 RA) and SGLT-2i groups are now routinely used for type 2 diabetes therapy and comprise a large number of medicinal products (Cheung et al., 2009; Lovshin and Drucker, 2009; Drucker et al., 2010).